A Special Request to Support Phase 3 Enrollment! 

We would greatly appreciate your support in recruitment of Phase 3 clinical trials. You can help by referring potential eligible participants who are currently living with PTSD, and by sharing details about the study with other providers. Please see included information and linked Provider letter at the bottom of this message to share with potential participants and other practitioners who may be interested in referring people.

Phase 3 Trials of MDMA-Assisted Psychotherapy for PTSD now enrolling!
 

Our Phase 3 clinical trials of MDMA-assisted psychotherapy for PTSD are currently recruiting participants within an hour’s drive of one of the 15 clinic sites across the United States, Canada, and Israel.
 

The Phase 3 clinical trials are assessing the efficacy and safety of MDMA-assisted psychotherapy in adult participants with severe PTSD.  

Over a 12-week treatment period, participants will be randomized to receive either MDMA with psychotherapy or psychotherapy only. Assignment to the group will be blinded throughout the study, and all participants will have twelve preparatory and integration sessions lasting 90 minutes each along with three day-long sessions about a month apart.  
 

Please read the information on this clinical trial including participant qualifications and clinic contact information visit the ClinicalTrials.gov website.  
 

Further information, including contact information for referrals for each site, can be found in the Study Letter to Providers.

The Phase 3 clinics are located:

• Los Angeles, CA | private practice

• San Francisco, CA | research institution

• San Francisco, CA | private practice

• Boulder, CO | private practice

• Fort Collins, CO | private practice

• New Orleans, LA | private practice

• New York, NY | research institution

• New York, NY | private practice

• Charleston, SC | private practice

• Madison, WI | research institution

• Boston, MA | private practice

• Montreal, Canada | private practice

• Vancouver, Canada | research institution

• Be’er Ya’akov, Israel | research institution

• Tel HaShomer, Israel | research institution

Thank you for your support! 

The MDMA Therapy Training Program